These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7760244

  • 1. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y, Ohi R, Yaoita S, Nakamura M, Kikuchi Y, Konno T, Tsuchiya S, Shiraishi H.
    J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
    [Abstract] [Full Text] [Related]

  • 2. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S, Zaizen Y, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Ueda K, Tasaka H, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Yano H, Akiyama H, Ikeda K.
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [Abstract] [Full Text] [Related]

  • 3. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 4. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
    Ishimoto K, Kiyokawa N, Fujita H, Yabuta K, Ohya T, Miyano T, Shinohara T, Sera Y.
    J Pediatr Surg; 1990 Apr 01; 25(4):398-401. PubMed ID: 2329455
    [Abstract] [Full Text] [Related]

  • 5. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
    Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, Esteve J, Thiesse P, Combaret V, Chauvot P, Boschetti R, David L, Brunat-Mentigny M, Philip T.
    Med Pediatr Oncol; 1997 Feb 01; 28(2):81-91. PubMed ID: 8986143
    [Abstract] [Full Text] [Related]

  • 6. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S.
    J Pediatr Surg; 2002 Jul 01; 37(7):949-54. PubMed ID: 12077747
    [Abstract] [Full Text] [Related]

  • 7. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T, Kohno S, Mimaya J, Hasegawa S, Urushihara N, Yoshida A, Kawano S, Kusafuka J, Horikoshi Y, Takashima Y, Aoki K, Hamazaki M.
    Pediatr Surg Int; 2004 Jan 01; 20(1):27-32. PubMed ID: 14689211
    [Abstract] [Full Text] [Related]

  • 8. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 01; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 9. Mass screening for neuroblastoma in Miyagi Prefecture.
    Itano M, Morita S, Fujie H, Ohashi Y, Minegishi N, Minegishi M, Yamaguchi Y, Sato T, Tsuchiya S, Konno T.
    Tohoku J Exp Med; 1992 Oct 01; 168(2):137-9. PubMed ID: 1306297
    [Abstract] [Full Text] [Related]

  • 10. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA, Hachitanda Y, Woods WG, Tuchman M, Lemieux B, Brisson L, Bernstein M, Brossard J, Leclerc JM, Byrne TD.
    Cancer; 1995 Dec 01; 76(11):2363-71. PubMed ID: 8635044
    [Abstract] [Full Text] [Related]

  • 11. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T, Ohta S, Tani T, Mizukuro T, Mekata E, Naitoh H, Shimadera S, Fujino S, Taga T.
    Pediatr Surg Int; 2002 Sep 01; 18(5-6):289-94. PubMed ID: 12415341
    [Abstract] [Full Text] [Related]

  • 12. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
    Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, Maeda K, Koide R, Hanawa Y, Tsunoda A.
    Lancet; 1984 Aug 04; 2(8397):271-3. PubMed ID: 6146820
    [Abstract] [Full Text] [Related]

  • 13. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
    Nishi M, Miyake H, Takeda T, Hanai J, Fujita K, Ichimiya H, Tanaka T, Hirama T, Ishikawa Y, Kudoh T, Azuma H, Takase A.
    Oncol Rep; 1998 Aug 04; 5(3):631-3. PubMed ID: 9538165
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
    Yokoyama S, Hirakawa H, Ueno S, Yabe H, Hiraoka N.
    Pediatrics; 1999 May 04; 103(5):e67. PubMed ID: 10224211
    [Abstract] [Full Text] [Related]

  • 16. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A.
    Gan To Kagaku Ryoho; 1990 Dec 04; 17(12):2319-26. PubMed ID: 2260868
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mass screening for neuroblastoma in Japan.
    Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y.
    Pediatr Hematol Oncol; 1991 Dec 04; 8(2):93-109. PubMed ID: 1863547
    [Abstract] [Full Text] [Related]

  • 20. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T.
    Cancer; 1984 Jun 15; 53(12):2731-5. PubMed ID: 6722733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.